Eunice S. Wang

Roswell Park Comprehensive Cancer Center

MedicineSocial Sciences

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 26 papers. Top paper: “Combination of dasatinib with chemotherapy in previously untreated core binding factor acute myeloid leukemia: CALGB 10801”.

Combination of dasatinib with chemotherapy in previously untreated core binding factor acute myeloid leukemia: CALGB 10801

Blood Advances(2020)10.1182/bloodadvances.2019000492

N/A

2.8DataRank · unranked

72 citations

Susan M. Geyer, Kristina Laumann, Weiqiang Zhao, Donna Bucci, Geoffrey L. Uy +12 more

Phase 2 study of ruxolitinib and decitabine in patients with myeloproliferative neoplasm in accelerated and blast phase

Blood Advances(2020)10.1182/bloodadvances.2020002119

N/A

2.2DataRank · unranked

73 citations

Raajit K. Rampal, Heidi Kosiorek, Rupali Bhave, Elizabeth O. Hexner, Eunice S. Wang +22 more

Phase 3 randomized trial of chemotherapy with or without oblimersen in older AML patients: CALGB 10201 (Alliance)

Blood Advances(2021)10.1182/bloodadvances.2021004233

N/A

1.0DataRank · unranked

30 citations

Guido Marcucci, Jun Yin, William Blum, Wendy Stock, Jessica Kohlschmidt +15 more

A precision medicine classification for treatment of acute myeloid leukemia in older patients

Journal of Hematology & Oncology(2021)10.1186/s13045-021-01110-5

N/A

0.719DataRank · unranked

15 citations

Jessica Kohlschmidt, Uma Borate, James S. Blachly, Shelley Orwick, Ann-Kathrin Eisfeld +15 more

BCOR and BCORL1 Mutations Drive Epigenetic Reprogramming and Oncogenic Signaling by Unlinking PRC1.1 from Target Genes

Blood Cancer Discovery(2021)10.1158/2643-3230.bcd-21-0115

N/A

0.564DataRank · unranked

42 citations

Helen C. Wang, Hannah Q. Karp, Clifford A. Meyer, Paloma Cejas, Micah D. Gearhart +22 more

Clinical and functional significance of circular RNAs in cytogenetically normal AML

Blood Advances(2020)10.1182/bloodadvances.2019000568

N/A

0.561DataRank · unranked

41 citations

Stefano Volinia, Deedra Nicolet, Michał Świerniak, Andreas Petri, Krzysztof Mrózek +18 more

PTPN11 Mutation Clonal Hierarchy in Acute Myeloid Leukemia

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.09.18.612239

N/A

0.165DataRank · unranked

2 citations

Chia Sharpe, K. R. Quinn, K. Dawn Bryant, Linde A. Miles, Robert L. Bowman +24 more

Impact of diagnostic genetics on remission MRD and transplantation outcomes in older patients with AML

Blood(2022)10.1182/blood.2021014520

N/A

0DataRank · unranked

74 citations

Haesook T. Kim, Nathan Denlinger, Pankit Vachhani, Bryan C. Hambley, Bryan Manning +18 more

Prediction of life-threatening and disabling bleeding in patients with AML receiving intensive induction chemotherapy

Blood Advances(2022)10.1182/bloodadvances.2021006166

N/A

0DataRank · unranked

25 citations

Manu Pandey, Yael Flamand, J. Erika Haydu, Roger Belizaire, Mark G. Faber +16 more

Small molecule MMRi62 targets MDM4 for degradation and induces leukemic cell apoptosis regardless of p53 status

Frontiers in Oncology(2022)10.3389/fonc.2022.933446

N/A

0DataRank · unranked

11 citations

Chao Xu, Samuel L. Galster, Javier Querol-García, Scott Portwood, Cory Mavis +12 more

A phase II study of CPX-351 in younger patients < 60 years old with secondary acute myeloid leukemia: Trial in progress.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.tps7073

N/A

0DataRank · unranked

0 citations

Salman Fazal, Elizabeth A. Griffiths, James E. Thompson, Pamela J. Sung, Steven Daniel Green +8 more

KDM6B protects T-ALL cells from NOTCH1-induced oncogenic stress

Research Square(2022)10.21203/rs.3.rs-2251777/v1

N/A

0DataRank · unranked

0 citations

Hassan Bjeije, Elisabeth Wilson, Aishwarya Krishnan, Wangisa Dunuwille, Tyler M. Parsons +11 more

KDM6B protects T-ALL cells from NOTCH1-induced oncogenic stress

Leukemia(2023)10.1038/s41375-023-01853-9

N/A

0DataRank · unranked

16 citations

Hassan Bjeije, Elisabeth R. Wilson, Aishwarya Krishnan, Wangisa M.B. Dunuwille, Tyler M. Parsons +11 more

Gemtuzumab ozogamicin plus standard induction chemotherapy improves outcomes of newly diagnosed intermediate cytogenetic risk acute myeloid leukemia

Blood Cancer Journal(2023)10.1038/s41408-023-00910-x

N/A

0DataRank · unranked

8 citations

Mina Abdelmalek, Tara Cronin, Jeffrey Baron, Zakariya Kashour, Farhan Azad +10 more

BIRC5 upregulation enhances DNMT3A-mutant T-ALL cell survival and pathogenesis

Blood Neoplasia(2024)10.1016/j.bneo.2024.100040

N/A

0DataRank · unranked

1 citations

William C. Wilson, Hassan Bjeije, Nancy Issa, Wentao Han, Tyler M. Parsons +12 more

Outcomes of relapsed or refractory acute myeloid leukemia after menin inhibition failure

Blood Advances(2025)10.1182/bloodadvances.2025018178

N/A

0DataRank · unranked

6 citations

Brian Ball, Yasmin Abaza, Jessica K. Altman, Rahul Thakur, Moiez Ali +12 more

Top advances of the year: Acute myeloid leukemia

Cancer(2025)10.1002/cncr.35834

N/A

0DataRank · unranked

5 citations

Eunice S. Wang, Rahul Thakur

Novel Inhibitors for MDM2-MDM4 E3 Ligase Potently Induce p53-Indepedent Apoptosis in Drug-Resistant Leukemic Cells

Molecules(2025)10.3390/molecules30010186

N/A

0DataRank · unranked

3 citations

Joseph M. Fose, Diana Martı́n, Inés G. Muñoz, Eunice S. Wang, Pamela J. Sung +3 more

Special considerations in the management of adult patients with acute leukaemias and myeloid neoplasms in the COVID-19 era: recommendations from a panel of international experts

The Lancet Haematology(2020)10.1016/s2352-3026(20)30205-2

N/A

0DataRank · unranked

97 citations

Prajwal Boddu, Mrinal M. Patnaik, Jan Philipp Bewersdorf, Maximilian Stahl, Raajit K. Rampal +47 more

Alemtuzumab in frontline therapy of adult acute lymphoblastic leukemia: Results of Cancer and Leukemia Group B 10102 (Alliance), a phase 1/2 study

Cancer(2025)10.1002/cncr.35750

N/A

0DataRank · unranked

3 citations

Jun Yin, Gerard Lozanski, Emily Curran, Gregory Malnassy, Krzysztof Mrózek +15 more

Phase I First-in-Human Dose Escalation Study of the oral SF3B1 modulator H3B-8800 in myeloid neoplasms

Leukemia(2021)10.1038/s41375-021-01328-9

N/A

0DataRank · unranked

183 citations

Martin Wermke, Virginia M. Klimek, Peter L. Greenberg, Patricia Font, Rami S. Komrokji +35 more

Germline variants drive myelodysplastic syndrome in young adults

Leukemia(2021)10.1038/s41375-021-01137-0

N/A

0DataRank · unranked

66 citations

Jane E. Churpek, Tom Walsh, Sioḃán Keel, Marja Hakkarainen, Thomas Schroeder +30 more

Inhibiting autophagy targets human leukemic stem cells and hypoxic AML blasts by disrupting mitochondrial homeostasis

Blood Advances(2021)10.1182/bloodadvances.2020002666

N/A

0DataRank · unranked

49 citations

Hannah Fay, Ashish C. Massey, Neng Yang, Matthew Johnson, Scott Portwood +3 more

Allelic Complexity of KMT2A Partial Tandem Duplications in Acute Myeloid Leukemia and Myelodysplastic Syndromes

medRxiv(2021)10.1101/2021.11.01.21265781

N/A

0DataRank · unranked

1 citations

Christopher J. Gibson, H. Moses Murdock, Phani K. Davineni, Marian H. Harris, Eunice S. Wang +5 more

BCOR and BCORL1 mutations disrupt PRC1.1 repressive function in leukemia by unlinking the RING-PCGF1 enzymatic core from target genes

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.03.08.433705

N/A

0DataRank · unranked

0 citations

Helen C. Wang, Clifford A. Meyer, Paloma Cejas, Micah D. Gearhart, Emmalee R. Adelman +21 more

Prediction of Life-threatening and Disabling Bleeding in Patients with Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy

medRxiv(2021)10.1101/2021.09.24.21263986

N/A

0DataRank · unranked

0 citations

Manu Pandey, Yael Flamand, J. Erika Haydu, Roger Belizaire, Rahul S. Vedula +15 more